A tale of two vaccinesBMJ 2018; 363 doi: https://doi.org/10.1136/bmj.k4152 (Published 04 October 2018) Cite this as: BMJ 2018;363:k4152
- Fiona Godlee, editor in chief
- The BMJ
Follow Fiona on Twitter @fgodlee
Public trust in vaccination programmes is crucial to their success. History tells us that trust is easily undermined by misinformation, but this should not prevent an open and informed debate on the evidence for the effectiveness and safety of vaccines.
Peter Doshi tells a tale of two vaccines rapidly deployed by GSK in 2009 amid fears of a flu pandemic (doi:10.1136/bmj.k3948). There were early internal safety reports showing a higher rate of serious adverse events logged in relation to one of the vaccines, Pandemrix, but these reports were not actively shared with the public, …